Mystery Checkpoint Revealed: KIR3DL3 Finally Found a Ligand in HHLA2

被引：13

作者：

Campbell, Kerry S. ^{[1
]}

机构：

[1] Fox Chase Canc Ctr, Inst Canc Res, 333 Cottman Ave, Philadelphia, PA 19111 USA

来源：

CANCER IMMUNOLOGY RESEARCH | 2021年 / 9卷 / 02期

关键词：

D O I：

10.1158/2326-6066.CIR-20-0996

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：128 / 128

页数：1

共 5 条

[1] KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory for Pathway to PD1 [J].

Bhatt, Rupal S. ;

Berjis, Abdulla ;

Konge, Julie C. ;

Mahoney, Kathleen M. ;

Klee, Alyssa N. ;

Freeman, Samuel S. ;

Chen, Chun-Hau ;

Jegede, Opeyemi A. ;

Catalano, Paul J. ;

Pignon, Jean-Christophe ;

Sticco-Ivins, Maura ;

Zhu, Baogong ;

Hua, Ping ;

Soden, Jo ;

Zhu, Jie ;

McDermott, David F. ;

Arulanandam, Antonio R. ;

Signoretti, Sabina ;

Freeman, Gordon J. .

CANCER IMMUNOLOGY RESEARCH, 2021, 9 (02) :156-169

[2] Expression, Clinical Significance, and Receptor Identification of the Newest B7 Family Member HHLA2 Protein [J].

Janakiram, Murali ;

Chinai, Jordan M. ;

Fineberg, Susan ;

Fiser, Andras ;

Montagna, Cristina ;

Medavarapu, Ramadevi ;

Castano, Ekaterina ;

Jeon, Hyungjun ;

Ohaegbulam, Kim C. ;

Zhao, Ruihua ;

Zhao, Aimin ;

Almo, Steven C. ;

Sparano, Joseph A. ;

Zang, Xingxing .

CLINICAL CANCER RESEARCH, 2015, 21 (10) :2359-2366

[3] Conservation, Extensive Heterozygosity, and Convergence of Signaling Potential All Indicate a Critical Role for KIR3DL3 in Higher Primates [J].

Leaton, Laura A. ;

Shortt, Jonathan ;

Kichula, Katherine M. ;

Tao, Sudan ;

Nemat-Gorgani, Neda ;

Mentzer, Alexander J. ;

Oppenheimer, Stephen J. ;

Deng, Zhihui ;

Hollenbach, Jill A. ;

Gignoux, Christopher R. ;

Guethlein, Lisbeth A. ;

Parham, Peter ;

Carrington, Mary ;

Norman, Paul J. .

FRONTIERS IN IMMUNOLOGY, 2019, 10

[4] Molecular characterization of KIR3DL3 [J].

Trundley, AE ;

Hiby, SE ;

Chang, CW ;

Sharkey, AM ;

Santourlidis, S ;

Uhrberg, M ;

Trowsdale, J ;

Moffett, A .

IMMUNOGENETICS, 2006, 57 (12) :904-916

[5] HHLA2 and PD-L1 co-expression predicts poor prognosis in patients with clear cell renal cell carcinoma [J].

Zhou, Qiang-Hua ;

Li, Kai-Wen ;

Chen, Xu ;

He, Hai-Xia ;

Peng, Sheng-Meng ;

Peng, Shi-Rong ;

Wang, Qiong ;

Li, Ze-An ;

Tao, Yi-Ran ;

Cai, Wen-Li ;

Liu, Ran-Yi ;

Huang, Hai .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)

← 1 →